About OPRD 2022 | Organic Process Research And Development
We are so excited to be bringing our Flagship Conference back as a Face to Face Conference and to welcome you to New Orleans, we have decided to move the conference from March to June 2022
DO YOU WANT TO IMPROVE EFFICIENCY AND INNOVATION IN YOUR SYNTHETIC ROUTE DESIGN, DEVELOPMENT, AND OPTIMISATION?
The efficient conversion of a chemical process into a process for manufacture on a tonnage scale has always been of importance in the chemical and pharmaceutical industries. However, in the current economic and regulatory climate, it has become increasingly vital and challenging to do so efficiently.
At the Organic Process Research & Development Conference, you will hear detailed presentations and case studies from top international chemists. Our hand-picked program of speakers has been put together specifically for an industrial audience. They will discuss the latest issues relating to synthetic route design, development, and optimization in the pharmaceutical, fine chemical, and allied fields.
Unlike other conferences, practically all our speakers are experts from the industry, which means the ideas and information you take home will be directly applicable to your own work.
The smaller numbers at our conferences create a more intimate atmosphere. You will enjoy plenty of opportunities to meet and network with speakers and fellow attendees during the reception, sit-down lunches, and extended coffee breaks in a relaxed and informal environment. Together, you can explore the different strategies and tactics evolving to meet today’s challenges.
*Book with Confidence! We understand that the situation regarding Covid is changing daily and want to reassure our customers that if you find you cannot attend due to Covid, we will issue a refund or transfer your booking to a later date.
WHO SHOULD ATTEND?
- Process Research & Development Chemists
- Chemical Engineers in Industry
- Heads of Departments & Team Leaders
HOW WILL YOU BENEFIT FROM ATTENDING?
- Benefit by hearing from key speakers who will present detailed case studies.
- Learn how to design for efficiency and optimise your development objectives.
- Access how industry strategies are evolving to meet today’s challenges.
- Learn how your peers are developing solutions to common problems.
- Gather important information on technical developments and equipment.
- Bring yourself up-to-date on current developments and future trends in pharmaceutical development.
- Meet and network with the key people working in the pharmaceutical industries.
- Save time by picking up essential tips from experts in their fields.
OUR PROGRAMME
Wednesday, June 22, 2022
8.15 am Registration and Morning Coffee
Morning Session Chair | Dr. John Studley, Scientific Update Ltd
8.55 am Opening Remarks
9.00 am
Dr Chris Senanayake | TCG GreenChem Inc., USA
Important Asymmetric and Catalytic Transformations for Drug Development
9.45 am Dr Daniel Zell | Genentech, USA
Development of a Manufacturing Process for the pan-RAF inhibitor Belvarafenib (GDC-5573)
10.30 am Coffee Break and Visit Exhibition Booths
11.15 am
Dr. Russell Cink | AbbVie, USA
Process Development for Glecaprevir
12.00 pm
Dr Rogelio P. Frutos | Boehringer Ingelheim, USA
Synthesis of PDE4B Inhibitors
12.45 pm Lunch and Visit Exhibition Booths
Afternoon Session Chair | Dr. Will Watson, Scientific Update Ltd
2.00 pm
Dr Philip Wheeler | Umicore, USA
Title to be confirmed
2.45 pm
Dr Alison Campbell Brewer | Eli Lilly, USA
Development and Scale-Up of a Direct Asymmetric Reductive Amination with Ammonia
3.30 pm Coffee Break and Visit Exhibition Booths
4.15 pm
Dr Masahiko Seki | Tokuyama Corporation, Japan
Novel and Efficient Catalytic System for Ketone Synthesis: An Expedient Approach to
Pharmaceuticals”
5.00 pm
Dr Emma Gardener | Cheminformatics Technologies, MilliporeSigma – A Business of Merck KGaA,
USA
SYNTHIA™ Retrosynthesis Software – Novel and efficient in silico pathway design validated at the
bench
5.45 pm End of Day 1
Welcome Drinks Reception
Thursday, June 23, 2022
Morning Session Chair
8.25 am Opening Remarks
8.30 am
Dr Andy (Aniruddh) Singh | Asha Pharma, USA
Cocrystals: A “New” Approach to Finding Suitable Drug Development Candidates
9.15 am
Dr Dustin Bringley | Gilead, USA
Process Development and Scale-Up in the Synthesis of Rovafovir Etalafenamide
10.00 am Coffee Break and Visit Exhibition Booths
10.45 am
Dr. Meghan Shaw | Merck, USA
Biocatalytic Redox Reactions for Green and Sustainable Processes
11.30 pm
Name to be confirmed | Organisation, Country
Title to be confirmed
12.15 pm Lunch and Visit Exhibition Booths
The conference adjourns after lunch.
2.00 pm – 5.00 pm
Optional Short Course | Organocatalysis- Using Small Molecules to Drive Synthetic Reactions
Dr John Studley | Scientific Update Ltd
Over the past decade the application of small-molecule organic catalysts to solve synthetic
problems have gained traction in both industrial and academic settings. A wide and expanding range
of catalyst classes and diverse activation modes in combination with increased mechanistic
understanding and practical applicability have fuelled their use across many areas of synthesis,
including asymmetric catalysis and the construction of important chiral molecules and building blocks.
Small molecule organic catalysts offer a range of practical advantages over macromolecular
(enzyme) or precious metal catalysts, including air and water stability, low cost, availability from
renewable resources and relatively low toxicity. Organocatalysis is recognized an inherently green
technology and often has no counterpart in the more established catalysis regimens. The 2021
chemistry Nobel prize was awarded to Benjamin List and David MacMillan for their pioneering work
in this area.
This short course will focus on the development and application of small molecule organocatalysts,
including examples and case studies from an industrial setting. The content will be of interest to
organic chemists- both in industry and academia- and anyone interested in finding out more about
this important area of catalysis.
Friday, June 24, 2022
Morning Session Chair | Dr John Studley, Scientific Update Ltd
8.25 am Opening Remarks
8.30 am
Dr Nga Do | Pfizer, USA
Title to be confirmed
9.15 am
Dr Stefanie Roeper | Vertex Pharmaceuticals, USA
Title to be confirmed
10.00 am Coffee Break and Visit Exhibition Booths
10.45 am Dr Thomas Kendall | Technobis, USA
Importance of Solid Form and Crystallization in the Removal of Impurities
11.30 pm
Dr David Ford | Snapdragon Chemistry, Inc., USA
Enabling Flow Chemistry R&D with Smart Tools to Manage Complexity
12.15 pm End of Day 3 and Conference
Boxed lunch available
For more event details, please visit the link below